Almotriptan (trade names Axert (US, Canada), Almogran (Belgium, Denmark, Finland, France, Germany, Italy, Ireland Portugal, Spain, the United Kingdom, the Netherlands, Sweden, Switzerland, South Korea… ), Almotrex (Italy) and Amignul (Spain)) is a triptan drug discovered and developed by Almirall for the treatment of heavy migraine headache. It is available in 12.5mg in most countries and also 6.25mg in US and Canada.

CAS：154323-57-6
中文别名：N,N-二甲基-2-(5-((吡咯烷-1-基磺酰基)甲基)-1H-吲哚-3-基)乙胺;阿莫曲坦;
英文别名：Axert;UNII-1O4XL5SN61;Almotriptan;Almogran;N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;
分子式：C17H25N3O2S
分子量：335.464
精确质量：335.167
Psa：64.79
Logp：3.2163

MDL号：MFCD00927104

密度：1.27 g/cm3
沸点：538.7ºC at 760 mmHg
闪点：279.6ºC

海关编码：2935009090

用途
抗偏头痛药。